UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Nature medicine, 2021-10, Vol.27 (10), p.1752-1760

2021

Volltextzugriff (PDF)

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Nature medicine, 2021-10, Vol.27 (10), p.1850-1850

2021

Volltextzugriff (PDF)

Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era

AIDS (London), 2021-06, Vol.35 (7), p.1103-1112

2021

Volltextzugriff (PDF)

Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

The Journal of infectious diseases, 2015-01, Vol.211 (2), p.178-186

2015

Volltextzugriff (PDF)

Positive Predictive Value of Epstein-Barr Virus DNA Detection in HIV-Related Primary Central Nervous System Lymphoma

Clinical infectious diseases, 2004-11, Vol.39 (9), p.1396-1397

2004

Volltextzugriff (PDF)

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy : a multicohort analysis

AIDS (London), 2008-09, Vol.22 (14), p.1759-1767

2008

Volltextzugriff (PDF)

Malnutrition in COVID-19 survivors: prevalence and risk factors

Aging clinical and experimental research, 2023-10, Vol.35 (10), p.2257-2265

2023

Volltextzugriff (PDF)

Clinical and Virological Monitoring During Treatment with Intrathecal Cytarabine in Patients with AIDS-Associated Progressive Multifocal Leukoencephalopathy

Clinical infectious diseases, 1999-03, Vol.28 (3), p.624-628

1999

Volltextzugriff (PDF)

Impaired CD4 T-Cell Count Response to Combined Antiretroviral Therapy in Antiretroviral-Naive HIV-Infected Patients Presenting With Tuberculosis as AIDS-Defining Condition

Clinical infectious diseases, 2012-03, Vol.54 (6), p.853-861

2012

Volltextzugriff (PDF)

Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma

AIDS (London), 2010-09, Vol.24 (15), p.2408-2412

2010

Volltextzugriff (PDF)

Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?

AIDS reviews, 2017-10, Vol.19 (3), p.119-133

2017

Volltextzugriff (PDF)

Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir

Haematologica (Roma), 2004-10, Vol.89 (10), p.1248

2004

Volltextzugriff (PDF)

The Effect of Potent Antiretroviral Therapy and JC Virus Load in Cerebrospinal Fluid on Clinical Outcome of Patients with AIDS-Associated Progressive Multifocal Leukoencephalopathy

The Journal of infectious diseases, 2000-10, Vol.182 (4), p.1077-1083

2000

Volltextzugriff (PDF)

The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells

Blood, 1998-08, Vol.92 (3), p.1011-1019

1998

Volltextzugriff (PDF)

Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy?

AIDS (London), 2005-10, Vol.19 (15), p.1691-1694

2005

Volltextzugriff (PDF)

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

AIDS (London), 2001-08, Vol.15 (12), p.1579-1581

2001

Volltextzugriff (PDF)

Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study

AIDS (London), 2000-07, Vol.14 (11), p.1660-1662

2000

Volltextzugriff (PDF)

Reply

The Journal of infectious diseases, 1999-11, Vol.180 (5), p.1752-1753

1999

Volltextzugriff (PDF)

Reply

The Journal of infectious diseases, 1999-11, Vol.180 (5), p.1752-1753

1999

Volltextzugriff (PDF)

Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma

Annals of neurology, 1999-02, Vol.45 (2), p.259-261

1999

Volltextzugriff (PDF)

Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/ hepatitis C virus co-infected patients

AIDS (London), 2004-07, Vol.18 (11), p.1602-1604

2004

Volltextzugriff (PDF)

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients. Commentary

AIDS (London), 2005, Vol.19 (15), p.1643-1694

2005

Volltextzugriff (PDF)

Mutations in genes associated with drug resistance in Mycobacterium tuberculosis isolates from Italy / Reply

The Journal of infectious diseases, 1999-11, Vol.180 (5), p.1751

1999

Volltextzugriff (PDF)

Definition and measurement of adherence to antiretroviral drugs in HIV-1-infected patients

The Lancet (British edition), 1999-06, Vol.353 (9168), p.1974-1974

1999

Volltextzugriff (PDF)

Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis

AIDS (London), 1995-12, Vol.9 (12), p.1343-1350

1995

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

KollektionPublisher website

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(31)
Humans
(30)
Infectious Diseases
(21)
Biological And Medical Sciences
(17)
Immunology
(17)
Male
(17)
Medical Sciences
(17)
Female
(16)
Aids/hiv
(14)
Adult
(12)
Hiv Infections - Drug Therapy
(12)
Virology
(12)
Viral Diseases
(11)
Human Viral Diseases
(10)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(10)
Anti-Hiv Agents - Therapeutic Use
(8)
Microbiology
(8)
Pharmacology. Drug Treatments
(8)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era

Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

Positive Predictive Value of Epstein-Barr Virus DNA Detection in HIV-Related Primary Central Nervous System Lymphoma

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy : a multicohort analysis

Malnutrition in COVID-19 survivors: prevalence and risk factors

Clinical and Virological Monitoring During Treatment with Intrathecal Cytarabine in Patients with AIDS-Associated Progressive Multifocal Leukoencephalopathy

Impaired CD4 T-Cell Count Response to Combined Antiretroviral Therapy in Antiretroviral-Naive HIV-Infected Patients Presenting With Tuberculosis as AIDS-Defining Condition

Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma

Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?

Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir

The Effect of Potent Antiretroviral Therapy and JC Virus Load in Cerebrospinal Fluid on Clinical Outcome of Patients with AIDS-Associated Progressive Multifocal Leukoencephalopathy

The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells

Structured treatment interruption in HIV-infected patients failing on multidrug therapy: is there a future for this strategy?

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study

Reply

Reply

Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma

Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/ hepatitis C virus co-infected patients

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients. Commentary

Mutations in genes associated with drug resistance in Mycobacterium tuberculosis isolates from Italy / Reply

Definition and measurement of adherence to antiretroviral drugs in HIV-1-infected patients

Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis

Aktive Filter

Suchergebnisse filtern